AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Kaposi Sarcoma Market Forecasts to 2030 – Global Analysis By Type (Classic Kaposi Sarcoma, Endemic Kaposi Sarcoma, Epidemic Kaposi Sarcoma, Immunosuppression-Associated Kaposi Sarcoma, Latrogenic Kaposi Sarcoma, Disseminated Kaposi Sarcoma and Other Types), Diagnostic Method, Treatment Modality, End User and By Geography
... Modality, End User and By Geography According to Stratistics MRC, the Global Kaposi Sarcoma Market is accounted for $108.69 million in 2023 and is expected to reach $150.92 million by 2030 growing at a CAGR ... Read More
-
APAC PCR-based Infectious Diseases Market - Industry Trends and Forecast to 2032
... a CAGR of 7.4% in the forecast period of 2024 to 2031. Market Segmentation Asia-Pacific PCR-based Infectious Diseases Market, By Test Type (Tuberculosis PCR Test, Hepatitis PCR Test, Human Immunodeficiency Virus (HIV) PCR Test, Influenza ... Read More
-
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
... is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia trachomatis Tests are carried out to diagnose infections, which can result in trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2024-2032
... and Region 2024-2032 The global cephalosporin market size reached US$ 19.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 2.6% ... Read More
-
Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and
... Africa) The global progressive multifocal leukoencephalopathy treatment market is set to experience steady growth from 2024 to 2031. Several key insights are driving this growth in the market: Factors Driving Market Growth: • Rising HIV ... Read More
-
Peripheral Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2030
... center markets. The global peripheral neuropathy market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are surge in geriatric and obese population and increasing ... Read More
-
Sexually Transmitted Infections (STIs) Global Market Report 2024
... By Route Of Administration: Oral; Parenteral5) By End-Users: Hospitals; Specialty Clinics; HomecareCovering: Pfizer Inc.; Johnson & Johnson; Roche Holdings AG; Merck & Co Inc.; AbbVie Inc. Sexually Transmitted Infections (STIs) Global Market Report 2024 from ... Read More
-
Womens Health Diagnostics Global Market Report 2024
... Testing; Prenatal Genetic Screening And Carrier Testing; Infectious Disease Testing; Sexually Transmitted Diseases (STD) Testing; Ultrasound Tests3) By End User: Hospitals And Clinics; Diagnostic And Imaging Centers; HomecareCovering: Becton Dickinson And Company; F. Hoffmann-La Roche ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Disease type (Chlamydia, Genital herpes, Gonorrhea), Product Type, Settings, End-user - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 99.74 billion in 2024, at a CAGR 5.90% to reach USD 141.12 billion by 2030. Global STD Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
HIV or AIDS Diagnostics Market by Product Type (Instruments, Kits & Reagents), Test Type (ELISA, Nucleic Acid Tests, Rapid Tests), End User - Global Forecast 2024-2030
... at USD 6.84 billion in 2023 and expected to reach USD 7.46 billion in 2024, at a CAGR 9.12% to reach USD 12.62 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Sponsor - Global Forecast 2024-2030
... USD 1.05 billion in 2023 and expected to reach USD 1.13 billion in 2024, at a CAGR 7.83% to reach USD 1.79 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
... 2028 The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. ... Read More
-
Cell Therapy Technologies Market based on By Therapy Type (Autologous, Allogenic), By Therapeutic Area (Oncology, CVD, Dermatology), By Region - Global Forecast up to 2030
... for a variety of disorders, including HIV/AIDS, cancer, and infectious diseases. It helps academics and healthcare practitioners to acquire insights into disease causes, illness development, and therapy responses using novel cellular-based techniques. Global population expansion, ... Read More
-
Herpes Simplex Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
... the hospital pharmacy, drug store, retail store, and online pharmacy markets. The global herpes simplex keratitis treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for ... Read More
-
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
... Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various ... Read More
-
United States In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others] By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F United States in vitro ... Read More
-
Australia In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Australia in vitro diagnostics ... Read More
-
India In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasis, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F India in vitro diagnostics market ... Read More
-
Japan In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan In Vitro Diagnostics Market size ... Read More
-
The World Market for Molecular Diagnostics, 12 th Edition
... in unexpected ways by COVID-19. But where does the multi-billion dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the ... Read More
-
Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... by 2028, exhibiting a growth rate (CAGR) of 11.40% during 2022-2028. Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and ... Read More
Research Assistance
